Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
Levamisole as an immunomodulator drug has been demonstrated to improve the immune response to Hepatitis B virus (HBV) vaccination in hemodialysis patients. The aim of this study was to evaluate the effect of levamisole supplementation on tetanus-diphtheria (Td) vaccine response rate in hemodialysis patients.
Epistemonikos ID: 6a20d66a06aba7d7ae495924c19138db64be3250
First added on: Nov 24, 2021